Clinical trial
Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
NCT00381589 is registered in ClinicalTrials.gov with Centre for Addiction and Mental Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Clozapine-Induced Hypersalivation Ipratropium Bromide
- Lead sponsor
- Centre for Addiction and Mental Health
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- Not reported
- Enrollment
- 25 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hypersalivation